Late Preterm Corticosteroids Exposure and Neurodevelopmental Outcomes.

An editorial examines the efficacy and safety of administering late preterm corticosteroids based on insights from the Antenatal Late Preterm Steroids (ALPS) trial and subsequent follow-up studies. It discusses the trade-offs between benefits and risks associated with corticosteroid exposure during the late preterm period and presents findings regarding neurodevelopmental outcomes in children exposed to these medications.